FDA to Co-Sponsor CGMP Conference in Baltimore

The FDA will co-sponsor the 'Redefining the 'C' in 'CGMP'' Conference in Baltimore on 4 – 5 June. The conference is the first joint ISPE-FDA conference focused on CGMP issues.

ISPE, the International Society for Pharmaceutical Engineering, announced Wednesday that the FDA will co-sponsor the "Redefining the 'C' in 'CGMP'" Conference in Baltimore on 4 – 5 June 2012.

The conference is the first joint ISPE-FDA conference focused on CGMP issues.

The two-day conference will feature a new format with a number of audience-participation and interactive sessions. A Hot Topic Discussion Forum between attendees and regulators will feature discussion on critical industry issues, concerns and collaboration. A mixed panel of FDA and industry leaders will also answer the industry's most pressing questions during a moderated "Meet the Press" session. Topical plenary and education sessions will be featured throughout the event.<